Letter to the Editor From Zandee and Links: "Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for I Administration".
作者信息
Zandee Wouter T, Links Thera P
机构信息
Department of Internal Medicine Division of Endocrinology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
出版信息
J Endocr Soc. 2023 Jan 25;7(3):bvad004. doi: 10.1210/jendso/bvad004. eCollection 2023 Jan 6.
Abstract
摘要
相似文献
1
Letter to the Editor From Zandee and Links: "Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for I Administration".赞迪和林克斯致编辑的信：“分化型甲状腺癌转移患者的生存不受碘给药准备方式的影响”。
J Endocr Soc. 2023 Jan 25;7(3):bvad004. doi: 10.1210/jendso/bvad004. eCollection 2023 Jan 6.
2
Response to Letter to the Editor from Zandee and Links: "Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for I Administration".对赞迪和林克斯致编辑信的回复：“转移性分化型甲状腺癌的生存不受碘给药准备方式的影响”。
J Endocr Soc. 2023 Jan 25;7(3):bvad005. doi: 10.1210/jendso/bvad005. eCollection 2023 Jan 6.
3
Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for I Administration.转移性分化型甲状腺癌的生存率不受碘给药准备方式的影响。
J Endocr Soc. 2022 Mar 2;6(5):bvac032. doi: 10.1210/jendso/bvac032. eCollection 2022 May 1.
4
Letter to the editor regarding "Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival".
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3622-3623. doi: 10.1007/s00259-022-05869-8. Epub 2022 Jun 15.
5
Letter to the Editor Regarding the Article "(124)I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image Analysis".
Thyroid. 2016 Aug;26(8):1141-2. doi: 10.1089/thy.2016.0180. Epub 2016 Jun 28.
6
Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes".
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5108-5109. doi: 10.1210/jc.2019-00634.
7
Response to Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes".
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5110-5111. doi: 10.1210/jc.2019-00851.
8
Letter to the Editor: What Is the Role of Serum Thyroglobulin Measurement in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine?致编辑的信：血清甲状腺球蛋白检测在未接受放射性碘治疗的分化型甲状腺癌患者中的作用是什么？
J Clin Endocrinol Metab. 2017 Jun 1;102(6):2113-2114. doi: 10.1210/jc.2016-3983.
9
Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.血清血管内皮生长因子水平在转移性分化型甲状腺癌中升高，但短期促甲状腺激素刺激不会使其升高。
J Clin Endocrinol Metab. 2002 Apr;87(4):1737-42. doi: 10.1210/jcem.87.4.8388.
10
Reply to the Letter to the Editor regarding "Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens".致编辑的信的回复，内容涉及“颈部清扫标本中偶然诊断出的颈部淋巴结转移性乳头状甲状腺癌的意义及处理”
Head Neck. 2020 Oct;42(10):3100. doi: 10.1002/hed.26391. Epub 2020 Aug 6.
引用本文的文献
1
Response to Letter to the Editor from Zandee and Links: "Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for I Administration".对赞迪和林克斯致编辑信的回复：“转移性分化型甲状腺癌的生存不受碘给药准备方式的影响”。
J Endocr Soc. 2023 Jan 25;7(3):bvad005. doi: 10.1210/jendso/bvad005. eCollection 2023 Jan 6.
本文引用的文献
1
Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for I Administration.转移性分化型甲状腺癌的生存率不受碘给药准备方式的影响。
J Endocr Soc. 2022 Mar 2;6(5):bvac032. doi: 10.1210/jendso/bvac032. eCollection 2022 May 1.
2
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南：美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
3
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer.重组人促甲状腺素（rhTSH）辅助放射性碘治疗残留或转移性分化型甲状腺癌。
Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD008302. doi: 10.1002/14651858.CD008302.pub2.
4
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal.与甲状腺激素撤药相比，接受重组人促甲状腺素诊断评估的甲状腺癌患者健康相关生活质量的短期变化比较。
J Clin Endocrinol Metab. 2006 Mar;91(3):878-84. doi: 10.1210/jc.2005-2064. Epub 2006 Jan 4.
Zotero 插件